Literature DB >> 22236917

DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008.

Y-F Yen1, T C Rodwell, M-Y Yen, H-C Shih, B-S Hu, L-H Li, Y-H Shie, P Chuang, R S Garfein.   

Abstract

OBJECTIVE: To determine whether patients receiving directly observed treatment (DOT) had lower all-cause mortality than those treated with self-administered treatment (SAT) and to identify factors associated with mortality among tuberculosis (TB) patients.
DESIGN: All TB patients in Taipei, Taiwan, diagnosed between 2006 and 2008 were included in a retrospective cohort study.
RESULTS: Among 3624 TB patients, 45.5% received DOT, which was disproportionately offered to older patients and those with more underlying illness and severe TB disease. After controlling for patients' sociodemographic factors, clinical findings and underlying comorbidities, the odds of death were 40% lower (aOR 0.60, 95%CI 0.5-0.8) among patients treated with DOT than those on SAT. After adjusting for DOT, independent predictors of death included non-Taiwan birth, increasing age, male, unemployment, end-stage renal disease requiring dialysis, malignancy, acid-fast bacilli smear positivity and pleural effusion.
CONCLUSION: DOT was associated with lower all-cause mortality after controlling for confounding factors. DOT should be expanded in Taiwan to improve critical treatment outcomes among TB patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236917      PMCID: PMC3289585          DOI: 10.5588/ijtld.11.0034

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  25 in total

1.  Exploring the determinants of treatment success for tuberculosis cases in Europe.

Authors:  D Falzon; Y Le Strat; F Belghiti; A Infuso
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

2.  Promoting adherence to treatment for tuberculosis: the importance of direct observation.

Authors:  Thomas R Frieden; John A Sbarbaro
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

3.  The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment.

Authors:  S H Cheng; T L Chiang
Journal:  JAMA       Date:  1997-07-09       Impact factor: 56.272

4.  Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial.

Authors:  E Wandwalo; N Kapalata; S Egwaga; O Morkve
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

5.  The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003.

Authors:  Aliko B Ahmed; Ibrahim Abubakar; Valerie Delpech; Marc Lipman; Delia Boccia; Josh Forde; Delphine Antoine; John M Watson
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

6.  Current status of treatment completion and fatality among tuberculosis patients in Spain.

Authors:  J A Caylà; J A Caminero; R Rey; N Lara; X Vallés; H Galdós-Tangüis
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

7.  Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004.

Authors:  Rachel Albalak; Richard J O'Brien; J Steve Kammerer; Sean M O'Brien; Suzanne M Marks; Kenneth G Castro; Marisa Moore
Journal:  Arch Intern Med       Date:  2007-12-10

8.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

Authors:  M Zwarenstein; J H Schoeman; C Vundule; C J Lombard; M Tatley
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

9.  Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.

Authors:  James N Newell; Sushil C Baral; Shanta B Pande; Dirgh Sing Bam; Pushpa Malla
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

10.  Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.

Authors:  Robert M Jasmer; Christopher B Seaman; Leah C Gonzalez; L Masae Kawamura; Dennis H Osmond; Charles L Daley
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405

View more
  4 in total

1.  Determinants of mortality in elderly patients with tuberculosis: a population-based follow-up study.

Authors:  Y-F Yen; J-Y Feng; S-W Pan; P-H Chuang; V Y-F Su; W-J Su
Journal:  Epidemiol Infect       Date:  2017-02-13       Impact factor: 4.434

2.  Patient and health care system characteristics are associated with delayed treatment of tuberculosis cases in Taiwan.

Authors:  Chien-Chou Chen; Po-Huang Chiang; Yen-Hsu Chen; I-Chun Fan; Ta-Chien Chan
Journal:  BMC Health Serv Res       Date:  2019-11-19       Impact factor: 2.655

3.  Pyrazinamide related prolonged drug-induced liver injury: A case report.

Authors:  Yeh-Chin Wang; Kai-Hsiang Chen; Yen-Lin Chen; Shu-Wen Lin; Wang-Da Liu; Jann-Tay Wang; Chien-Ching Hung
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

4.  Directly observed therapy reduces tuberculosis-specific mortality: a population-based follow-up study in Taipei, Taiwan.

Authors:  Yung-Feng Yen; Muh-Yong Yen; Yi-Ping Lin; Hsiu-Chen Shih; Lan-Huei Li; Pesus Chou; Chung-Yeh Deng
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.